Any process that stops, prevents or reduces the rate, frequency or extent of the chemical reactions involving RNA.

The deposition or aggregation of coloring matter in an organism, tissue or cell.

Any process that modulates the frequency, rate or extent of the formation from simpler components of hemoglobin, an oxygen carrying, conjugated protein containing four heme groups and globin.

Any process that activates or increases the rate, frequency or extent of the chemical reactions involving RNA.

The clustering and aggregation of lipid rafts at a single cellular pole during activation of particular cell types, such as lymphocytes.

negative regulation of hemoglobin biosynthesis

negative regulation of hemoglobin synthesis

Any process that stops, prevents or reduces the rate, frequency or extent of the formation from simpler components of hemoglobin, an oxygen carrying, conjugated protein containing four heme groups and globin.

The directed orientation of lymphocyte signaling molecules and associated lipid rafts towards a chemokine gradient or a contact point with an appropriate activating cell.

galactosyl beta-1,4 N-acetylglucosamine beta-1,3 glucuronosyltransferase activity

Catalysis of the transfer, in a beta 1,3 linkage, of D-glucuronic acid (GlcUA) from UDP-GlcUA to N-acetyllactosamine (galactosyl beta-1,4-N-acetylglucosamine).

The directed orientation of T cell signaling molecules and associated lipid rafts towards a chemokine gradient or a contact point with antigen presenting cell.

Stops, prevents or reduces the activity of the enzyme phospholipase A2.

Catalysis of the transfer, in a beta 1,3 linkage, of D-glucuronic acid (GlcUA) from UDP-GlcUA to asioloorosomucoid.

The process of creating protein polymers, compounds composed of a large number of component monomers; polymeric proteins may be made up of different or identical monomers. Polymerization occurs by the addition of extra monomers to an existing poly- or oligomeric protein.

The rupture of cell membranes and the loss of cytoplasm.